Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans.

Berardelli, R; Margarito, E; Ghiggia, F; Picu, A; Balbo, M; Bonelli, L; Giordano, R; Karamouzis, I; Bo, M; Ghigo, E; Arvat, E

Berardelli, R; Margarito, E; Ghiggia, F; Picu, A; Balbo, M; Bonelli, L; Giordano, R; Karamouzis, I; Bo, M; Ghigo, E; Arvat, E.

Affiliation

Berardelli R; Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin, Corso Dogliotti 14, Turin, Italy.

J Endocrinol Invest ; 33(9): 657-62, 2010 Oct.

Article in En | MEDLINE | ID: mdl-20414043

Subject(s)

Aging/physiology; Citalopram/pharmacology; Neurosecretory Systems/drug effects; Adrenocorticotropic Hormone/blood; Adult; Aged; Aging/blood; Aging/drug effects; Citalopram/administration & dosage; Citalopram/adverse effects; Dehydroepiandrosterone/blood; Humans; Hydrocortisone/blood; Infusions, Intravenous; Male; Middle Aged; Neurosecretory Systems/physiology; Placebos; Selective Serotonin Reuptake Inhibitors/administration & dosage; Selective Serotonin Reuptake Inhibitors/adverse effects; Selective Serotonin Reuptake Inhibitors/pharmacology; Time Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aging / Citalopram / Neurosecretory Systems Type of study: Clinical_trials Limits: Adult / Aged / Humans / Male / Middle aged Language: En Journal: J Endocrinol Invest Year: 2010 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google